top of page

RESEARCH

PUBLICATIONS

GNB1 Publications

2025

  • The possible association of two novel heterozygous GNB1 variants with obesity and metabolic disorders

Karantza M, Lee H, Kitsiou S, et al. The possible association of two novel heterozygous GNB1 variants with obesity and metabolic disorders. Hormones (Athens, Greece). 2025;24(1):283-286. doi:https://doi.org/10.1007/s42000-024-00615-1

https://pubmed.ncbi.nlm.nih.gov/39581956/

​

  • Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene

Street D, Teare L, Georgieva T, et al. Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene. Parkinsonism & related disorders. Published online July 2025:107822. doi:https://doi.org/10.1016/j.parkreldis.2025.107822

https://pubmed.ncbi.nlm.nih.gov/40210557/

2024

2023

2022

2021

2020

2019

2018

2017

2016

G-protein Publications

2025

  • Integrative proteomic and lipidomic analysis of GNB1 and SCARB2 knockdown in human subcutaneous adipocytes

Kitamoto T, Kitamoto A. Integrative proteomic and lipidomic analysis of GNB1 and SCARB2 knockdown in human subcutaneous adipocytes. Loor JJ, ed. PLOS ONE. 2025;20(3):e0319163. doi:https://doi.org/10.1371/journal.pone.0319163

https://pubmed.ncbi.nlm.nih.gov/40127054/

2023

2022

2021

2006

Therapies and Drug-related

2025

  • Hit identification for membrane protein drug discovery

Rawlins P. Hit identification for membrane protein drug discovery. Drug Target Review. 2025. 

https://www.drugtargetreview.com/article/158267/advancements-in-hit-identification-for-membrane-protein-drug-discovery/ 

2023

2013

2012

Thanks for submitting!

The GNB1 Advocacy Group is a 501(c)(3) public charity. Our tax identification number is 99-1719087.

© 2025 GNB1 Advocacy

bottom of page